Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix

This publication has 42 references indexed in Scilit:

• Matrix Metalloproteinase 2 Immunoreactive Protein Appears Early in Cervical Epithelial Dedifferentiation
  Gynecologic Oncology, 1999
• Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix—Clinicopathologic Study Using Immunohistochemistry and mRNAin SituHybridization
  Gynecologic Oncology, 1999
• Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase Immunostaining
  Gynecologic Oncology, 1996
• Characterization of Matrix‐degrading Proteinases and Their Inhibitors Secreted by Human Gynecological Carcinoma Cells
  Japanese Journal of Cancer Research, 1995
• Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues
  International Journal of Cancer, 1994
• In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrix
  Journal of Neuro-Oncology, 1994
• The matrix‐degrading metalloproteinases
  BioEssays, 1992
• Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia
  JNCI Journal of the National Cancer Institute, 1992
• The origin of matrix metalloproteinases and their familial relationships
  FEBS Letters, 1991
• Human gelatinase/type IV procollagenase is a regular plasma component
  FEBS Letters, 1989